Clinical Trials Logo

Clinical Trial Summary

Adenoid hypertrophy is a common cause of airway obstruction in children; it may lead to mouth breathing, nasal discharge, snoring, sleep apnea, and hyponasal speech.


Clinical Trial Description

Adenoid hypertrophy is a common cause of airway obstruction in children; it may lead to mouth breathing, nasal discharge, snoring, sleep apnea, and hyponasal speech. It also contributes to the pathogenesis of rhinosinusitis and recurrent otitis media. However, the adenoid lies in the posterior nasopharyngeal wall and may act as a pad against the palate facilitating velopharyngeal closure, especially in patients with palatal abnormalities; Its presence can compensate for a short or poorly mobile palate. Following adenoidectomy, compensation is eliminated and velopharyngeal insufficiency (VPI) may result. Therefore, patients with palatal abnormalities (such as poor palatal mobility, short palate, occult submucosal cleft palate, scarred palate after previous tonsillectomy, and repaired cleft palate) are at high risk to develop hypernasality after complete adenoidectomy, and in such situations conservative or partial adenoidectomy is performed ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05273853
Study type Interventional
Source Sohag University
Contact Dina A Hasb Allah, Resident
Phone +201286000163
Email dina_ewaida_post@med.sohag.edu.eg
Status Recruiting
Phase N/A
Start date February 4, 2022
Completion date December 1, 2022

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03604822 - Music Therapy Protocol to Support Bulbar and Respiratory Functions in ALS N/A
Not yet recruiting NCT05492266 - Expiratory Muscle Strength Training for Hypernasal Speech in Children N/A